<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00271544</url>
  </required_header>
  <id_info>
    <org_study_id>241</org_study_id>
    <nct_id>NCT00271544</nct_id>
  </id_info>
  <brief_title>Attain Model 4196 Left Ventricular (LV) Lead</brief_title>
  <official_title>Attain Model 4196 Left Ventricular (LV) Lead</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart failure is a progressive disease that decreases the pumping action of the heart. This
      may cause a backup of fluid in the heart and may result in heart beat changes. When there are
      changes in the heart beat sometimes an implantable heart device is used to control the rate
      and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of
      the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may
      be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the
      upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles
      through three or four leads (flexible insulated wires) that are inserted through the veins to
      the heart. The purpose of this study is to evaluate a new lead for delivering energy to the
      left ventricle (bottom left chamber of the heart).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">August 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety (Subjects Without a Model 4196 Lead Related Complication)</measure>
    <time_frame>One Month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy (Pacing Voltage Thresholds of Distal Tip Electrode)</measure>
    <time_frame>One Month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy (Pacing Voltage Threshold of Proximal Ring Electrode)</measure>
    <time_frame>Three Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjects Successfully Implanted With Model 4196 Lead</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects Successfully Implanted After Cannulation</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All Left Ventricular Leads</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All Medtronic Left Ventricular Leads (Attain Family)</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cannulation Time</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy Time</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Model 4196 Lead Placement Time</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Implant Time</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Lead Handling Characteristics</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical Performance - Tip Electrode: Sensing</measure>
    <time_frame>12-month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical Performance - Tip Electrode: LV Voltage Threshold</measure>
    <time_frame>12-month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical Performance -Tip Electrode: Pacing Impedance</measure>
    <time_frame>12-month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical Performance -Ring Electrode: Sensing</measure>
    <time_frame>Implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical Performance - Ring Electrode: LV Voltage Threshold</measure>
    <time_frame>12-month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical Performance -Ring Electrode: Pacing Impedance</measure>
    <time_frame>12-Month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summarize All Adverse Events</measure>
    <time_frame>Up to 18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">190</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>4196 Lead</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non-randomized study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacing Lead</intervention_name>
    <description>implant and follow-up of study device</description>
    <arm_group_label>4196 Lead</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  QRS greater than or equal to 120 milliseconds (The QRS interval is a measurement of
             how the electrical signal involved in a heart beat travels, or is conducted, through
             the ventricles. A wide QRS (more than 120) suggests that there is a conduction
             problem, or block, in the ventricles.)

          -  Left Ventricular Ejection Fraction (EF) less than or equal to 35 percent (Ejection
             Fraction is a measurement of how well the left ventricle pumps blood out to the rest
             of the body. The higher the EF the more blood the ventricle is pumping.)

          -  Subject has moderate to severe heart failure despite medications

        Exclusion Criteria:

          -  Subjects with a previous lead in the left ventricle or previous implant attempt within
             30 days of implant or ongoing complications from a previous unsuccessful attempt

          -  Subjects with chest pain or who have had a heart attack within the past month before
             enrollment in the study

          -  Subjects that have had certain surgeries on their heart within the past three months

          -  Subjects with chronic (permanent) fast heart beats in the upper chambers of the heart
             (atrial arrhythmias)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Ramza, MD, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Luke's Mid America Heart Institute, Kansas City MO</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Davenport</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mayfield Heights</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sainte-Foy</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2005</study_first_submitted>
  <study_first_submitted_qc>December 30, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2006</study_first_posted>
  <results_first_submitted>April 30, 2009</results_first_submitted>
  <results_first_submitted_qc>July 9, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 25, 2009</results_first_posted>
  <disposition_first_submitted>September 24, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>September 24, 2009</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">September 28, 2009</disposition_first_posted>
  <last_update_submitted>September 24, 2009</last_update_submitted>
  <last_update_submitted_qc>September 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>4196 Clinical Trial Leader</name_title>
    <organization>Medtronic, Inc.</organization>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>cardiac pacing</keyword>
  <keyword>left ventricular lead</keyword>
  <keyword>cardiac resynchronization therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Total number of patients enrolled after meeting inclusion/exclusion criteria was 190. Total number of patients that received an implant attempt was 186. Total number of patients with a 4196 lead attempt was 177. Total number of patients successfully implanted with a 4196 lead was 170. Some data was not reported and deviations were recorded.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>4196 Lead</title>
          <description>Subjects underwent Model 4196 left ventricular lead implant attempt</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="190">Total number of subjects enrolled.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Implant Attempted</title>
              <participants_list>
                <participants group_id="P1" count="186">Total number of subjects completed baseline and underwent system implant attempt.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Model 4196 Lead Attempted</title>
              <participants_list>
                <participants group_id="P1" count="177">Total number of subjects attempted Model 4196 lead.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="170">Total number subjects successfully implanted 4196 lead.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Subjects did not receive a 4196 lead</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Model 4196 lead not attempted</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Implant not attempted</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>4196 Lead</title>
          <description>Subjects underwent Model 4196 left ventricular lead implant attempt</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="186"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>All subjects who underwent an implant attempt (186) were included in the study population analyses.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <description>All subjects who underwent an implant attempt (186) were included in the study population analyses.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.1" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>All subjects who underwent an implant attempt (186) were included in the study population analyses.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>New York Heart Association</title>
          <description>All subjects who underwent an implant attempt (186) were included in the study population analyses. Some subjects did not report data or data was outside the criteria, this was captured as a protocol deviation.</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Class III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Class IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race / Ethnicity</title>
          <description>All subjects who underwent an implant attempt (186) were included in the study population analyses.</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Columbian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sri Lankan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subject chose not to provide</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Intrinsic QRS Width</title>
          <description>All subjects who underwent an implant attempt (186) were included in the study population analyses. Some subjects did not report data or data was outside the criteria, this was captured as a protocol deviation.</description>
          <units>Milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="153.1" spread="24.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular Ejection Fraction</title>
          <description>All subjects who underwent an implant attempt (186) were included in the study population analyses. Some subjects did not report data or data was outside the criteria, this was captured as a protocol deviation. Left ventricular ejection fraction is the fraction of blood pumped out of the left ventricle with each heartbeat. For this measurement, the fraction is presented as a percent.</description>
          <units>Percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.2" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Safety (Subjects Without a Model 4196 Lead Related Complication)</title>
        <description>A subject who was free of a Model 4196 lead related complication by one month visit.</description>
        <time_frame>One Month</time_frame>
        <population>Subjects who underwent a Model 4196 left ventricular (LV) lead implant attempt and completed 1-month visit; or experienced Model 4196 lead related complications by 1-month visit.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects who underwent Model 4196 left ventricular lead implant attempt</description>
          </group>
        </group_list>
        <measure>
          <title>Safety (Subjects Without a Model 4196 Lead Related Complication)</title>
          <description>A subject who was free of a Model 4196 lead related complication by one month visit.</description>
          <population>Subjects who underwent a Model 4196 left ventricular (LV) lead implant attempt and completed 1-month visit; or experienced Model 4196 lead related complications by 1-month visit.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168" lower_limit="92" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>One sample proportion</param_type>
            <param_value>0.955</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>0.955</ci_upper_limit>
            <estimate_desc>1-side 95% confidence limit lower bound</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects Successfully Implanted With Model 4196 Lead</title>
        <description>A successful implant occurs when the Model 4196 lead is implanted in the left ventricle of the heart and functions appropriately.</description>
        <time_frame>Implant</time_frame>
        <population>Subjects who underwent Model 4196 lead implant attempt.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects who underwent Model 4196 LV lead implant attempt</description>
          </group>
        </group_list>
        <measure>
          <title>Subjects Successfully Implanted With Model 4196 Lead</title>
          <description>A successful implant occurs when the Model 4196 lead is implanted in the left ventricle of the heart and functions appropriately.</description>
          <population>Subjects who underwent Model 4196 lead implant attempt.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>One sample proportion</param_type>
            <param_value>0.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.932</ci_lower_limit>
            <ci_upper_limit>0.989</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Efficacy (Pacing Voltage Thresholds of Distal Tip Electrode)</title>
        <description>Model 4196 lead distal tip electrode mean pacing voltage threshold (at 0.5 milliseconds [ms])</description>
        <time_frame>One Month</time_frame>
        <population>Subjects with pacing threshold at tip electrode captured at 0.5 milliseconds (ms) at 1-month visit.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects with tip electrode threshold capture at 0.5ms at 1-month</description>
          </group>
        </group_list>
        <measure>
          <title>Efficacy (Pacing Voltage Thresholds of Distal Tip Electrode)</title>
          <description>Model 4196 lead distal tip electrode mean pacing voltage threshold (at 0.5 milliseconds [ms])</description>
          <population>Subjects with pacing threshold at tip electrode captured at 0.5 milliseconds (ms) at 1-month visit.</population>
          <units>volts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="160"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>One sample mean</param_type>
            <param_value>1.1</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.9</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.1</ci_lower_limit>
            <ci_upper_limit>1.2</ci_upper_limit>
            <estimate_desc>1-side 95% confidence limit upper bound</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Efficacy (Pacing Voltage Threshold of Proximal Ring Electrode)</title>
        <description>Model 4196 lead proximal ring electrode mean pacing voltage threshold (at 0.5 milliseconds [ms])</description>
        <time_frame>Three Months</time_frame>
        <population>Subjects with pacing threshold at ring electrode captured at 0.5 milliseconds (ms) at 3-month visit.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects with ring electrode threshold captured at 0.5ms at 3-month</description>
          </group>
        </group_list>
        <measure>
          <title>Efficacy (Pacing Voltage Threshold of Proximal Ring Electrode)</title>
          <description>Model 4196 lead proximal ring electrode mean pacing voltage threshold (at 0.5 milliseconds [ms])</description>
          <population>Subjects with pacing threshold at ring electrode captured at 0.5 milliseconds (ms) at 3-month visit.</population>
          <units>volts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>One sample mean</param_type>
            <param_value>1.9</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.0</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_lower_limit>1.9</ci_lower_limit>
            <ci_upper_limit>2.2</ci_upper_limit>
            <estimate_desc>1-sided 97.5% confidence limit upper bound</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjects Successfully Implanted After Cannulation</title>
        <description>A successful implant occurs when the coronary sinus (CS) is successfully cannulated and a left ventricular lead is implanted in the left ventricle of the heart and functions appropriately.</description>
        <time_frame>Implant</time_frame>
        <population>Subjects with successful CS cannulation after an incision was made (implant attempt)</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects who underwent an implant attempt with successful CS cannulation</description>
          </group>
        </group_list>
        <measure>
          <title>Subjects Successfully Implanted After Cannulation</title>
          <description>A successful implant occurs when the coronary sinus (CS) is successfully cannulated and a left ventricular lead is implanted in the left ventricle of the heart and functions appropriately.</description>
          <population>Subjects with successful CS cannulation after an incision was made (implant attempt)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="183"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>One sample proportion</param_type>
            <param_value>0.989</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.974</ci_lower_limit>
            <ci_upper_limit>1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Left Ventricular Leads</title>
        <description>All left ventricular leads successfully implanted</description>
        <time_frame>Implant</time_frame>
        <population>Subjects who underwent an implant attempt.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects who underwent an implant attempt</description>
          </group>
        </group_list>
        <measure>
          <title>All Left Ventricular Leads</title>
          <description>All left ventricular leads successfully implanted</description>
          <population>Subjects who underwent an implant attempt.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>One sample proportion</param_type>
            <param_value>0.973</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.950</ci_lower_limit>
            <ci_upper_limit>0.996</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Medtronic Left Ventricular Leads (Attain Family)</title>
        <description>All Medtronic left ventricular leads (Lead Model Numbers included 4193, 4194, 4195 and 4196) successfully implanted</description>
        <time_frame>Implant</time_frame>
        <population>Subjects who underwent an implant attempt.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects who underwent an implant attempt</description>
          </group>
        </group_list>
        <measure>
          <title>All Medtronic Left Ventricular Leads (Attain Family)</title>
          <description>All Medtronic left ventricular leads (Lead Model Numbers included 4193, 4194, 4195 and 4196) successfully implanted</description>
          <population>Subjects who underwent an implant attempt.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>One sample proportion</param_type>
            <param_value>0.973</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.950</ci_lower_limit>
            <ci_upper_limit>0.996</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cannulation Time</title>
        <description>Cannulation time was defined as the time from insertion of the first CS cannulation catheter to the first CS cannulation.</description>
        <time_frame>Implant</time_frame>
        <population>Subjects successfully implanted with a Model 4196 lead.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects successfully implanted with a Model 4196 lead</description>
          </group>
        </group_list>
        <measure>
          <title>Cannulation Time</title>
          <description>Cannulation time was defined as the time from insertion of the first CS cannulation catheter to the first CS cannulation.</description>
          <population>Subjects successfully implanted with a Model 4196 lead.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fluoroscopy Time</title>
        <description>Fluoroscopy time was defined as the total time the fluoroscope was imaging.</description>
        <time_frame>Implant</time_frame>
        <population>Subjects successfully implanted with a Model 4196 lead.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects successfully implanted with a Model 4196 lead</description>
          </group>
        </group_list>
        <measure>
          <title>Fluoroscopy Time</title>
          <description>Fluoroscopy time was defined as the total time the fluoroscope was imaging.</description>
          <population>Subjects successfully implanted with a Model 4196 lead.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.2" spread="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Model 4196 Lead Placement Time</title>
        <description>Model 4196 lead placement time was defined as the time from insertion of the successfully placed lead to the time when it was placed in the first acceptable pacing location.</description>
        <time_frame>Implant</time_frame>
        <population>Subjects successfully implanted with a Model 4196 lead.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects successfully implanted with a Model 4196 lead</description>
          </group>
        </group_list>
        <measure>
          <title>Model 4196 Lead Placement Time</title>
          <description>Model 4196 lead placement time was defined as the time from insertion of the successfully placed lead to the time when it was placed in the first acceptable pacing location.</description>
          <population>Subjects successfully implanted with a Model 4196 lead.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.9" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Implant Time</title>
        <description>Total implant time was defined as time from initial incision to final closure.</description>
        <time_frame>Implant</time_frame>
        <population>Subjects successfully implanted with a Model 4196 lead.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects successfully implanted with a Model 4196 lead</description>
          </group>
        </group_list>
        <measure>
          <title>Total Implant Time</title>
          <description>Total implant time was defined as time from initial incision to final closure.</description>
          <population>Subjects successfully implanted with a Model 4196 lead.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117.1" spread="101.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Lead Handling Characteristics</title>
        <description>Lead handling characteristics assessed as &quot;acceptable&quot; by physicians</description>
        <time_frame>Implant</time_frame>
        <population>All available assessments from physicians.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects who underwent Model 4196 left ventricular lead implant attempt</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Lead Handling Characteristics</title>
          <description>Lead handling characteristics assessed as &quot;acceptable&quot; by physicians</description>
          <population>All available assessments from physicians.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Electrical Performance - Tip Electrode: Sensing</title>
        <description>Model 4196 lead tip electrode R-wave amplitude</description>
        <time_frame>12-month</time_frame>
        <population>Subjects with Model 4196 lead implanted and an intrinsic R-wave available at 12-month visit.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects with tip electrode R-wave amplitude at 12-month</description>
          </group>
        </group_list>
        <measure>
          <title>Electrical Performance - Tip Electrode: Sensing</title>
          <description>Model 4196 lead tip electrode R-wave amplitude</description>
          <population>Subjects with Model 4196 lead implanted and an intrinsic R-wave available at 12-month visit.</population>
          <units>millivolt (mV)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.0" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Electrical Performance - Tip Electrode: LV Voltage Threshold</title>
        <description>Model 4196 lead tip electrode LV voltage threshold</description>
        <time_frame>12-month</time_frame>
        <population>Subjects with Model 4196 lead implanted and 12-month visit completed.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects with tip electrode threshold captured at 0.5ms at 12-month</description>
          </group>
        </group_list>
        <measure>
          <title>Electrical Performance - Tip Electrode: LV Voltage Threshold</title>
          <description>Model 4196 lead tip electrode LV voltage threshold</description>
          <population>Subjects with Model 4196 lead implanted and 12-month visit completed.</population>
          <units>Volts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="131"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Electrical Performance -Tip Electrode: Pacing Impedance</title>
        <description>Model 4196 lead tip electrode pacing impedance</description>
        <time_frame>12-month</time_frame>
        <population>Subjects with Model 4196 lead implanted and 12-month visit completed.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects with tip electrode pacing impedance at 12-month</description>
          </group>
        </group_list>
        <measure>
          <title>Electrical Performance -Tip Electrode: Pacing Impedance</title>
          <description>Model 4196 lead tip electrode pacing impedance</description>
          <population>Subjects with Model 4196 lead implanted and 12-month visit completed.</population>
          <units>Ohms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="508.7" spread="144.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Electrical Performance -Ring Electrode: Sensing</title>
        <description>Model 4196 lead ring electrode R-wave amplitude</description>
        <time_frame>Implant</time_frame>
        <population>Subjects with Model 4196 lead implanted and with intrinsic R-wave amplitude at implant.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects with ring electrode R-wave amplitude at implant</description>
          </group>
        </group_list>
        <measure>
          <title>Electrical Performance -Ring Electrode: Sensing</title>
          <description>Model 4196 lead ring electrode R-wave amplitude</description>
          <population>Subjects with Model 4196 lead implanted and with intrinsic R-wave amplitude at implant.</population>
          <units>mV</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="162"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.4" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Electrical Performance - Ring Electrode: LV Voltage Threshold</title>
        <description>Model 4196 lead ring electrode LV voltage threshold</description>
        <time_frame>12-month</time_frame>
        <population>Subjects with Model 4196 lead implanted and 12-month visit completed.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects with ring electrode threshold captured at 0.5ms at 12-month</description>
          </group>
        </group_list>
        <measure>
          <title>Electrical Performance - Ring Electrode: LV Voltage Threshold</title>
          <description>Model 4196 lead ring electrode LV voltage threshold</description>
          <population>Subjects with Model 4196 lead implanted and 12-month visit completed.</population>
          <units>Volts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Electrical Performance -Ring Electrode: Pacing Impedance</title>
        <description>Model 4196 lead ring electrode pacing impedance</description>
        <time_frame>12-Month</time_frame>
        <population>Subjects with Model 4196 lead implanted and completed 12-month visit.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>Subjects with ring electrode pacing impedance at 12-month</description>
          </group>
        </group_list>
        <measure>
          <title>Electrical Performance -Ring Electrode: Pacing Impedance</title>
          <description>Model 4196 lead ring electrode pacing impedance</description>
          <population>Subjects with Model 4196 lead implanted and completed 12-month visit.</population>
          <units>Ohms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="497.1" spread="262.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Summarize All Adverse Events</title>
        <description>All adverse events were collected for this trial such as, but not limited to, the following: Atrial Fibrillation, Chest Pain, Pneumonia, Cold/Flu</description>
        <time_frame>Up to 18 months</time_frame>
        <population>All subjects enrolled into the 4196 study.</population>
        <group_list>
          <group group_id="O1">
            <title>4196 Lead</title>
            <description>All enrolled subjects</description>
          </group>
        </group_list>
        <measure>
          <title>Summarize All Adverse Events</title>
          <description>All adverse events were collected for this trial such as, but not limited to, the following: Atrial Fibrillation, Chest Pain, Pneumonia, Cold/Flu</description>
          <population>All subjects enrolled into the 4196 study.</population>
          <units>adverse events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Generally, contracts allow investigators to publish study results per the protocol and publication plan. Medtronic reviews publications to determine if confidential information (&quot;CI&quot;) is included. Any such CI is deleted before publication. Medtronic may not censor/interfere with the publication. Investigators may publish single-site publications after a decision by Medtronic that no multi-site study publication will be done or 12 months after the study is closed, whichever is earlier.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hang Nguyen</name_or_title>
      <organization>Medtronic CRDM Clinical Research</organization>
      <phone>800-328-2518 ext 62832</phone>
      <email>hang.t.nguyen@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

